Literature DB >> 18446170

Evidence vs experience in the surgical management of necrotizing enterocolitis and focal intestinal perforation.

C J Hunter1, N Chokshi, H R Ford.   

Abstract

INTRODUCTION: Necrotizing enterocolitis (NEC) and focal intestinal perforation (FIP) are neonatal intestinal emergencies that affect premature infants. Although most cases of early NEC can be successfully managed with medical therapy, prompt surgical intervention is often required for advanced or perforated NEC and FIP.
METHODS: The surgical management and treatment of FIP and NEC are discussed on the basis of literature review and our personal experience.
RESULTS: Surgical options are diverse, and include peritoneal drainage, laparotomy with diverting ostomy alone, laparotomy with intestinal resection and primary anastomosis or stoma creation, with or without second-look procedures.
CONCLUSIONS: The optimal surgical therapy for FIP and NEC begins with prompt diagnosis and adequate fluid resuscitation. It appears that there is no significant difference in patient outcome based on surgical management alone. However, the infant's weight, comorbidities, surgeon preference and timing of intervention should be taken into account before operative intervention.

Entities:  

Mesh:

Year:  2008        PMID: 18446170     DOI: 10.1038/jp.2008.44

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  15 in total

Review 1.  Hepatic portal venous gas: physiopathology, etiology, prognosis and treatment.

Authors:  Bassam Abboud; Jad El Hachem; Thierry Yazbeck; Corinne Doumit
Journal:  World J Gastroenterol       Date:  2009-08-07       Impact factor: 5.742

2.  Management of neonatal spontaneous intestinal perforation by peritoneal needle aspiration.

Authors:  M Gébus; J-L Michel; S Samperiz; L Harper; J-L Alessandri; D Ramful
Journal:  J Perinatol       Date:  2017-11-09       Impact factor: 2.521

3.  Definitive peritoneal drainage in the extremely low birth weight infant with spontaneous intestinal perforation: predictors and hospital outcomes.

Authors:  B M Jakaitis; A M Bhatia
Journal:  J Perinatol       Date:  2015-04-09       Impact factor: 2.521

4.  Rho kinase inhibition maintains intestinal and vascular barrier function by upregulation of occludin in experimental necrotizing enterocolitis.

Authors:  Justyna S Grothaus; Guillermo Ares; Carrie Yuan; Douglas R Wood; Catherine J Hunter
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-06-21       Impact factor: 4.052

5.  Primary laparotomy is effective and safe in the treatment of necrotizing enterocolitis.

Authors:  Stefan Gfroerer; Henning Fiegel; Rolf L Schloesser; Udo Rolle
Journal:  World J Surg       Date:  2014-10       Impact factor: 3.352

6.  Hospital and neurodevelopmental outcomes of extremely low-birth-weight infants with necrotizing enterocolitis and spontaneous intestinal perforation.

Authors:  T A Shah; J Meinzen-Derr; T Gratton; J Steichen; E F Donovan; K Yolton; B Alexander; V Narendran; K R Schibler
Journal:  J Perinatol       Date:  2011-12-08       Impact factor: 2.521

7.  Development of artificial neural networks for early prediction of intestinal perforation in preterm infants.

Authors:  Joonhyuk Son; Daehyun Kim; Jae Yoon Na; Donggoo Jung; Ja-Hye Ahn; Tae Hyun Kim; Hyun-Kyung Park
Journal:  Sci Rep       Date:  2022-07-15       Impact factor: 4.996

8.  Neonatal stomas: does a separate incision avoid complications and a full laparotomy at closure?

Authors:  Rania Kronfli; Kirsty Maguire; Gregor Murray Walker
Journal:  Pediatr Surg Int       Date:  2012-12-20       Impact factor: 1.827

9.  More than a gut feeling: predicting surgical necrotising enterocolitis.

Authors:  Jörn-Hendrik Weitkamp
Journal:  Gut       Date:  2013-09-24       Impact factor: 23.059

10.  Neonatal independent predictors of severe NEC.

Authors:  Miriam Duci; Francesco Fascetti-Leon; Marta Erculiani; Elena Priante; Maria Elena Cavicchiolo; Giovanna Verlato; Piergiorgio Gamba
Journal:  Pediatr Surg Int       Date:  2018-04-11       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.